NL-OMON29043已完成1 期
Safety and preliminary efficacy of Alkaline Phosphatase in severely burned patients
Rode Kruis Ziekenhuis0 个研究点目标入组 10 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 已完成
- 发起方
- 入组人数
- 10
研究概览
简要总结
none
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •partial/full thickness acute thermal burns of at least 15% TBSA • Admission burn ICU • Age =18 • Written informed consent from patient or legal representative
排除标准
- •Inclusion in another interventional clinical trial • Age < 18 • Age > 80 • Patients who are pregnant or lactating • Patients expected to have fatal disease within 24 hours • Patients who have advanced chronic liver disease confirmed by a Child-Pugh C • Patients who are having an known history of immune system that has been impaired by disease, such as patients with HIV and with a CD4 count of less than 200 cells/mm, neutropenic patients (<0.5 x 109/l) or medical treatment with immunosuppressive effects • Patients with active haematological malignancy
研究者
相似试验
进行中（未招募）
1 期
Safety and preliminary efficacy of Alkaline Phosphatase in severely burned patientsEUCTR2019-004826-12-NLAssociation of Dutch Burn Centres10
已完成
2 期
Safety and preliminary efficacy of Alkaline Phosphatase in severely burned patientsNL-OMON52814Rode Kruis Ziekenhuis10
已完成
不适用
Safety and efficacy of polyphosphate for the treatment of ulcerative colitis(AMU002-CR01)JPRN-UMIN000021555Asahikawa Medical University10
已完成
3 期
Tooth cavity disinfetion with Chitosan solution in 5-12 year old childreCTRI/2023/06/053795Dr Sreejeeta Dey96
已完成
3 期
Evaluation of the efficacy and safety of the potassium citrate tablet of immediate release vs Acalka® in urolithiasis in adults.Male Urogenital DiseasesRenal urolithiasisNephrolithiasisKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesUrolithiasisRPCEC00000333Oriente Pharmaceutical Laboratory Company